Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, Mounjaro can cause dizziness in some people. It appears on the side-effect profile documented in the medicine's SmPC and is reported by a subset of patients, particularly in the early weeks of treatment or after a dose increase. It is rarely severe, but it is worth understanding what is likely behind it and when it warrants attention. Mounjaro (tirzepatide) is a prescription-only medicine; a GPhC-registered prescriber reviews every consultation before treatment begins, which means questions exactly like this one get a proper clinical answer rather than a guess.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: it's day four of your first Mounjaro pen. You've eaten less than usual because your appetite has noticeably dropped, you may have had some nausea, and you stood up too quickly from the sofa. The room tilted. That sequence is probably the most common reason dizziness appears in the early weeks of tirzepatide treatment.
Mounjaro slows gastric emptying and suppresses appetite — which is the mechanism behind the weight loss. As a consequence, some people eat and drink considerably less than they normally would, and that reduction in caloric and fluid intake can drop blood pressure slightly when you change position. This is sometimes called postural or orthostatic hypotension, and dizziness on standing is its characteristic symptom.
Mild dehydration compounds the picture. Nausea (another common early side effect documented on the NHS tirzepatide medicines page) can make the idea of drinking water unappealing, and if fluid intake drops, so can blood pressure. Eating small, regular meals and staying well hydrated tends to help significantly. None of this requires you to push through and say nothing; it is exactly the kind of feedback a prescriber needs to know about.
The good news is that for most people this phase is short. The 2.5mg starting dose is deliberately low to let your system adapt, and if you are wondering whether Mounjaro can make you dizzy, the answer is yes for some people, though it tends to track the side-effect curve, noticeable early, then settling within days to a couple of weeks.
If you have been on Mounjaro for several weeks and felt fine, then moved up to the next strength, a return of light-headedness is not unusual. Each dose step changes the degree of appetite suppression and gastric slowing, and your body goes through a shorter version of the same adjustment it made at the start.
This is worth flagging because patients sometimes worry that dizziness appearing weeks into treatment means something has gone wrong. It hasn't, in most cases. The prescriber who reviewed your consultation will have noted your dose history and any relevant medical background, and a follow-up message to the clinical team is always appropriate if a symptom is bothering you.
There is a useful overview of the broader experience of being on tirzepatide, including how the early weeks tend to feel, on our page on how Mounjaro makes you feel, worth reading alongside this one if you are in the adjustment phase.
People with type 2 diabetes who are also taking medicines that lower blood glucose need to be especially alert. Our page explaining why you might feel dizzy on Mounjaro covers this distinction in more detail, because dizziness can be a sign of low blood sugar (hypoglycaemia) in that context, and that is a different situation requiring a different response. Tell your prescriber if this applies to you.
Most dizziness on Mounjaro resolves by itself. Some does not, and it is important to know the difference.
Contact a doctor promptly (or call 999 in an emergency) if dizziness is severe or sudden, if you faint or nearly faint, if it comes with chest pain or shortness of breath, or if it does not ease after a few days. The same applies if you are vomiting so much that you cannot keep fluids down, since that level of dehydration can compound the situation quickly.
The MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk exists for exactly this kind of report. Tirzepatide carries a Black Triangle (▼) status, meaning the MHRA actively invites reports from patients experiencing side effects, however minor they seem. It takes about five minutes and contributes to the post-market safety picture for everyone on this medicine.
On the subject of safety review: at nume, every prescription is reviewed by a named GPhC-registered Independent Prescriber before anything is dispensed. If you have concerns about a symptom and want clinical input rather than a Google answer, our support team is available seven days a week.
You cannot always prevent dizziness entirely, but several things reliably reduce its frequency. Drink enough water, more than you might feel like doing when nausea is present. Eat small amounts regularly rather than skipping meals altogether, even when your appetite is low. Rise slowly from sitting or lying positions, especially first thing in the morning. Avoid alcohol, which lowers blood pressure independently and will add to any effect the medicine is producing.
If driving or operating machinery feels unsafe, do not do it. That is not an overreaction, it is what the prescribing information advises.
Our FAQs cover a range of common practical questions about starting Mounjaro, and our Mounjaro overview page has a fuller picture of the medicine's mechanism, evidence base and licensing, including a section on whether Mounjaro is an SGLT2 inhibitor, which is a question that comes up often when people are comparing it with other treatments. For context on what treatment through a regulated UK pharmacy involves (including costs) the Mounjaro prices page sets out what is included in a private prescription at nume. If you are considering starting treatment and want your full medical picture reviewed by a prescriber, starting a free consultation is the next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.